Antimalarial drug resistence and artemisinin based combination therapy : a bio-economic model for elucidating policy choices
Antimalarial drug resistance is a major cause of the increasing burden due to P. falciparum malaria. Artemisinin-based combination therapies (ACTs) are now recognised to be the ideal choice for the first-line treatment of uncomplicated malaria, in order to achieve two beneficial outcomes: improvemen...
Main Author: | Yeung, Shunmay |
---|---|
Other Authors: | Mills, A. ; White, N. |
Published: |
London School of Hygiene and Tropical Medicine (University of London)
2006
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.429187 |
Similar Items
-
Range, quality and costs of antimalarial drugs available in the retail sector in Kenya
by: Amin, Abdinasir Abass
Published: (2005) -
Contemporary approaches to malaria chemotherapy : novel quinoline and peroxide-based antimalarial drugs
by: Mukhtar, Amira
Published: (2005) -
The synthesis and metabolism of novel 4-aminoquinoline antimalarials
by: Shone, Alison Emily
Published: (2007) -
New concepts for malaria chemotherapy and approaches to improved antimalarial endoperoxides
by: ArauÌjo, Nuna
Published: (2004) -
Design and synthesis of new dihydroorotate dehydrogenase inhibitors as potential antimalarials
by: Davies, Matthew
Published: (2007)